Conditions: Diabetes Diabetes Mellitus, Type 2
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 7637
Healthy volunteers: no

Brief summary:
This trial is conducted globally. The aim of this trial is to compare cardiovascular safety of insulin degludec versus insulin glargine in subjects with type 2 diabetes at high risk of cardiovascular events.

Detailed description:

Arms:
arm 1: All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product. arm 2: All subjects will continue their current antidiabetic therapy except for the basal insulin component (if any) that will be replaced by the investigational product.

Interventions: intervention 1: insulin degludec intervention 2: insulin glargine
Intervention descriptions: intervention 1: Injected once daily subcutaneously (s.c., under the skin) intervention 2: Injected once daily subcutaneously (s.c., under the skin)

Protocol document: